GL1X · GenesisL1 explorer

Research workbench

Neuraminidase of A/BREVIG MISSION/1/1918 H1N1 strain in complex with zanamivir

Analyse Neuraminidase of A/BREVIG MISSION/1/1918 H1N1 strain in complex with zanamivir in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3B7E
Type
protein
Length
770 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase
EC
3.2.1.18
UniProt
Q9IGQ6
Ligands
ZMR, NAG, FUC, CA
Pockets
4 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNeuraminidase (EC 3.2.1.18)protein3853% helix, 46% strandQ9IGQ6

Ligands and binding sites

  • ZMR · Zanamivir · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains B, A
  • FUC · alpha-L-fucopyranose · sugar
  • CA · Calcium ion · metal · 5 copies · chains A, B
  • GOL · Glycerol · additive · 9 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12640.610.8044ZMR
21850.590.8231ZMR
31880.540.7922empty
4980.370.7519empty

Interfaces

1 interface between chains.

  • A–B · 1582 Ų buried · 23 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 16 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 3B7E · Neuraminidase of A/Brevig Mission/1/1918 H1N1 strain in complex with zanamivir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.